Commercial proptech platform for professional commercial property assessors.
Since the founding of Ruffena Capital in 2013, we have worked with over 170 clients across a wide range of sectors, stages and types of financing. We are sector and stage agnostic, however we and our investors generally have an appetite for businesses with a compelling proposition that is growing in the market, and led by exceptional management.
Commercial proptech platform for professional commercial property assessors.
An innovative and commercially orientated biotechnology and pharmaceutical business at the cutting edge of stem cell research.
This company is building on and commercialising a discovery by MD Andersen Cancer Centre, Texas, which significantly improves outcomes from established cancer treatments.
A clinical phase biotechnology company dedicated to the development of highly innovative first-in-class antibacterials.
With its income from fulfilling art sales, the key to this business’ delivery is through online IT based ordering, serving professional level image creators and curators.
Offering clothing companies a sustainable colouring method, the business developed an improved dying process for textile fibre, reducing the environmental impact compared to the traditional dyeing process.
Leading global mobile app management and commercialisation platform, with an international team and market.
A patient-focused medical foods business operating in a niche area between supplements and pharmaceuticals.
A Canada based biopharmaceutical company focused on the rapid development and production of specialty antibody and protein drugs.